| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $3.20B | - | |
| 10% | 22.15M | $626.41M | - | |
| Pres | 18.68M | $528.20M | - | |
| CEO | 16.74M | $473.30M | -289,774 | |
| Dir | 15.13M | $427.80M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $29.59 | $5,918,000.00 | -10.8% | - | - | |
| Apr 16, 2026 | Gline Matthew | CEO | Sell | 289,774 | $29.16 | $8,449,809.84 | -1.7% | - | - | |
| Mar 26, 2026 | Fitzgerald Meghan | Director | Sale+OE | 70,000 | $27.45 | $1,921,500.00 | -62.0% | - | - | |
| Feb 13, 2026 | Gold Daniel Allen73 | Director | Sell | 1,225,784 | $26.64 | $32,658,518.16 | -1.6% | - | - | |
| Feb 13, 2026 | Qvt Financial LP75 | Director By Deputization | Sell | 1,225,784 | $26.64 | $32,658,518.16 | -1.6% | - | - | |
| Feb 13, 2026 | Manchester Keith S46 | Director | Sell | 1,225,784 | $26.64 | $32,658,518.16 | -1.6% | - | - | |
| Jan 12, 2026 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $21.92 | $4,384,000.00 | -10.8% | +27.3% | - | |
| Dec 31, 2025 | Sukhatme Mayukh | President &CIO | Sale+OE | 1,330,868 | $21.72 | $28,902,500.47 | -3.3% | +27.6% | - | |
| Dec 24, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 275,000 | $22.47 | $6,179,750.00 | -7.8% | +19.4% | - | |
| Dec 23, 2025 | Pulik Richard | CFO | Sale+OE | 406,731 | $22.43 | $9,122,307.09 | -39.4% | +24.4% | - |